Showing 2 posts of 2 posts found.
Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …
MHRA awards Innovation Passports to liver cancer and dementia medicines
Scottish NHS hospital adopts light-activated therapy to reduce surgical infections
Manchester launches nurse-led clinic to improve kidney transplant outcomes
Androlabs and Majorelle expand testosterone therapy into France
Promatix secures Innovate UK funding to advance bispecific ADC programme